CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Open-market sale President and CEO sold 19,642 shares at $4.86 ($95,460)
- 4 Open-market sale Chief Financial Officer sold 6,433 shares at $4.95 ($31,843)
- 4 Open-market sale Chief Medical Officer sold 7,764 shares at $4.95 ($38,432)
- 4 Open-market sale General Counsel sold 6,831 shares at $4.95 ($33,813)
- 4 Open-market sale Chief Business Officer sold 5,147 shares at $4.95 ($25,478)
- 4 Open-market sale President and CEO sold 18,338 shares at $4.95 ($90,773)
- 4 Open-market buy 10% owner bought 1,538,461 shares at $3.25 ($4,999,998)
- 4 Open-market buy President and CEO bought 6,500 shares at $3.81 ($24,765)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 24,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 832 shares at $4.93 ($4,102)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Open-market sale Chief Business Officer sold 5,829 shares at $4.24 ($24,715)
- 4 Open-market sale Chief Medical Officer sold 6,416 shares at $4.24 ($27,204)
Page 7 of 18 · 354 filings